Logo

German Congress of Orthopaedics and Traumatology (DKOU 2025)

Deutsche Gesellschaft für Orthopädie und Unfallchirurgie (DGOU), Deutsche Gesellschaft für Orthopädie und Orthopädische Chirurgie (DGOOC), Deutsche Gesellschaft für Unfallchirurgie (DGU), Berufsverband für Orthopädie und Unfallchirurgie (BVOU)
28.-31.10.2025
Berlin


Meeting Abstract

Proximal femoral replacement in revision total hip arthroplasty for severe femoral bone loss: A 20-year experience

Nils Meißner 1,2
Mason Carstens 1
Dirk Larson 1
Nicholas Bedard 1
Charles Hannon 1
Matthew Abdel 1
1Department of Orthopedic Surgery, Mayo Clinic, Rochester, USA
2Klinik für Operative Orthopädie, Sana Kliniken Sommerfeld, Kremmen, Deutschland

Text

Objectives and questions: Proximal femoral replacement (PFR) is a salvage procedure in revision total hip arthroplasty (THA) for extensive femoral bone loss. This study aimed to evaluate implant survivorship and clinical outcomes of PFR for non-oncologic indications at midterm follow-up.

Material and methods: Sixty-one consecutive PFRs for non-oncologic indications performed between 2000 and 2022 at a single academic institution were reviewed. The most common indication was periprosthetic fracture and reimplantation after periprosthetic joint infection (each 33%), followed by aseptic loosening (31%) and dislocation (3%). Femoral bone loss was severe in all patients, with 49% Paprosky type IIIb defects and 51% Paprosky type IV defects. The majority of PFRs were cemented (98%). Constrained liners were used in 26 patients (43%), while standard head-liner constructs were used in 25 patients (41%) and dual-mobility constructs in 10 patients (16%). Outcomes of interest included implant survivorship, mortality rates, and clinical outcomes. Revision, reoperation, dislocation, and aseptic failures were considered as time-to-event outcomes, and were analyzed using the cumulative incidence function, accounting for the competing risk of death. The mean patient age was 77 years, with 67% being female. Mean follow-up was 5 years.

Results: The 5-year cumulative incidence of any revision and any revision of the femoral component was 24% and 8%, respectively (Figure 1 [Fig. 1]). The 5-year cumulative incidence of any reoperation was 30%. Dislocation was the most common reason for revision (n=8), with a 5-year cumulative incidence of 15%, followed by periprosthetic joint infection (n=4), periprosthetic fracture (n=2), and aseptic loosening (n=1). Among the 10 patients who dislocated, 8 patients (80%) underwent revision to a constrained liner at a mean of 2 years. The 5-year cumulative incidence of revision for aseptic loosening of the PFR was 2%. The 2- and 5-year mortality rates were 14% and 42%, respectively.

Figure 1: Cumulative incidence of revision with death as a competing risk factor.

Discussion and conclusions: In this complex cohort of 61 PFRs for non-oncologic revision THA, revision and reoperation rates were modest, with dislocation as the predominant failure mode. Although aseptic loosening was rare, mortality remained high.